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Protease activity is a characteristic common to many allergens. Allergen source-derived proteases interact with lung epithelial cells,
which are now thought to play vital roles in both innate and adaptive immune responses. Allergen source-derived proteases act on
airway epithelial cells to induce disruption of the tight junctions between epithelial cells, activation of protease-activated receptor-
2, and the production of thymic stromal lymphopoietin. These facilitate allergen delivery across epithelial layers and enhance
allergenicity or directly activate the immune system through a nonallergic mechanism. Furthermore, they cleave regulatory cell
surface molecules involved in allergic reactions. Thus, allergen source-derived proteases are a potentially critical factor in the
development of allergic sensitization and appear to be strongly associated with heightened allergenicity.
1.Introduction
Asthma is regarded as an inﬂammatory disorder of the
airways and has generally been recognized as being driven by
Thelper2-(Th2-)sk ewedThcelldiﬀerentiation.Th2-driven
cytokines, interleukin (IL)-4 and IL-13, trigger B cells to syn-
thesize IgE, while IL-5 plays a role in eosinophil maturation
andsurvival,andIL-13regulatesairwayhyperresponsiveness
and mucus hyperplasia.
Epithelial cells clearly play important roles in the initi-
ation of Th2 cell responses to allergens. The epithelial cell
layer also acts as a molecular sieve that excludes invaders
and plays an important role in homeostasis. Barrier function
disorder due to ﬁlaggrin (FLG) mutations is critical in the
pathogenesis of atopic dermatitis [1]. Although FLG is not
expressed in the lower airway respiratory epithelium [2],
barrier function of the airway epithelium is impaired in
asthma, showing shared common underlying pathogenic
mechanisms.
Taking these ﬁndings together, asthma can be viewed as a
diseaseofbothexcessiveactivationandimpairmentofairway
epithelial barrier function [3–5].
Sources of allergens, such as pollen, house dust mites
(HDMs), cockroaches, and fungi, may produce or contain
proteases and thereby activate and disrupt the epithelial
barrier, causing greater sensitization.
This paper focuses on the importance of allergen source-
derived proteases as a factor contributing to primary sensi-
tization to allergens and to exacerbation of allergic disorders
secondary to impaired epithelial barrier function.
2.Allergen Source-DerivedProteases
Environmental exposure to allergens is an important deter-
minant of the prevalence of asthma. Allergen source-derived
proteases act not only as allergens, but also as promoters of
allergenicity.
2.1. Pollens. Pollen allergens have protease activity. The
pollens of Japanese cedar (Cryptomeria japonica), Japanese
cypress (Chamaecyparis obtusa), and Rocky Mountain
juniper (Juniperus scopulorum) contain serine protease activ-
ity [6]. An aspartic protease was also recently identiﬁed in
Japanese cedar pollen allergen [7]. In grass, two serine pro-
teases from short ragweed (Ambrosia artemisiifolia) pollen
have been puriﬁed and characterized [8, 9]. Kentucky blue
grass (Poa pratensis), rye grass (Lolium perenne), and
Bermuda grass (Cynodon dactylon), pollen have also been2 Journal of Allergy
characterized. These pollens exhibited peptidase activity,
which appeared to be from serine proteases, but cystein
protease activity was also detected in Kentucky and rye
grass pollen [10]. Grass pollen major group 1 allergens are
reported to be cysteine proteases [11, 12]. The pollens of
white birch (Betulaalba) and short ragweed contain not only
serine but also cysteine protease activity [6, 13].
2.2. HDMs. HDMs produce cysteine and serine proteases.
Dermatophagoides pteronyssinus 1( D e rp1 )a n dD e rp3
[14] are cysteine proteases. Der p 6 and Der p 9 are
serine proteases [15–17]. Interestingly, Der p 2, which
lacks apparent protease activity, is a structural mimic of
MD2, a component of the Toll-like receptor-4 (TLR-4)
complex, and can reconstitute a TLR4 signaling complex
[18], independently of protease eﬀects.
2.3. Cockroaches. American cockroach (Periplaneta ameri-
cana)a n dG e r m a nc o c k r o a c h( Blattella germanica)a l l e r g e n
extracts have complex proteolytic activities [19–21]. An
approximately 28kDa trypsin-like serine protease (Per a
10) was puriﬁed and characterized from the whole body
extract of American cockroaches [22, 23] .B l ag2 ,ap o t e n t
allergen from German cockroaches, has been identiﬁed as
an aspartic protease [24, 25]. German cockroach extract
is rich in proteases and exerts direct proinﬂammatory
eﬀects on airway epithelial cells. These proinﬂammatory
eﬀects are abolished by serine inhibitors [26], suggesting the
involvement of a serine protease. However, the presence and
activities of proteases in cockroach extracts, especially those
targetingaspartate,cysteine,andserine,remaincontroversial
[27].
2.4.Fungi. Alargenumberofmoldspeciesareknowntohar-
bor proteases. Serine proteases of airborne fungi have been
identiﬁed in Penicillium, Aspergillus, Rhodotorula, Curvu-
laria,a n dCladosporium species [28–31]. Cross-reactivity has
been reported among fungal species [32–35]. The active
proteaseofEpicoccumpurpurascens,Epip1,whichisapotent
fungal allergen source inducing respiratory allergic disorders
worldwide, also plays an important role in driving allergic
responses in the airways of murine models [36].
Recent research has focused on the role of exogenous
allergen proteases in allergic disorders. Enzymatic activities
have been proposed to facilitate sensitization to various
allergens [37–39].
3. Disruptionof Epithelial-CellBarrier
In the clinical setting of asthma, there is evidence that the
barrier function of the airway epithelium is impaired [40–
43]. The airway epithelium serves as a barrier via the forma-
tion of tight junctions (TJs) which seal oﬀ the paracellular
space.TJsalsohavegatefunctionsthatregulatethepassageof
ions and macromolecules through the paracellular pathway.
TJs are comprised of a series of interacting proteins and
receptors including zonula occludens (ZOs) proteins ZO-
1–3, occludin, claudins 1–5, and transmembrane adhesion
proteins (β-catenin, E-cadherin, and junctional adhesion
molecule-1). These proteins and receptors appear to interact
in a homophilic manner. ZO-1, -2, and -3 bind to the
cytoplasmic tail of occludin and link the TJ to the actin
cytoskeleton. Occludin appears to copolymerize to form
claudin-based TJ strands. Claudins adhere to each other in
a homotypic as well as a heterotypic manner, determining
the barrier properties of cell-cell contact existing between
twoneighboringcells,andregulateparacellularpermeability.
Regulatory molecules, including tyrosine kinases, proteases,
and GTPases, colocalize near the tight junction. Coordinated
functions between the transmembrane components and
cytoplasmic molecules, along with the cytoskeleton and
regulatory molecules, play a crucial role in not only barrier
function but also communication between adjacent cells as
well as in the regulation of intercellular transport [44, 45].
Initiation of sensitization to allergens in the airway is
preceded by their uptake and processing by a subpopulation
of mucosal dendritic cells (DCs), followed by presentation of
speciﬁc peptide epitopes to na¨ ıve T cells in association with
major histocompatibility (MHC) class II. Mucosal DCs are
positionedwithintheepithelium.DCsextendtheirprocesses
between epithelial cells directly into the airway lumen,
as a periscope function that allows continuous immune
surveillance of the airway luminal surface. DCs form TJs
with epithelial cells through their expression of adhesion
molecules and via E-cadherin homotypic interactions [46,
47].
DCs act as immune sentinels by alerting T cells to
the presence of antigens after delivery and presentation to
draining lymph nodes. In mice, antigen administered into
thelungsisrapidly,thatis,inaslittleas12hours,transported
to thoracic lymph nodes [48, 49]. The path taken by inhaled
antigens from the airways to sampling by DC subsets has
yet to be characterized in detail. Antigen sampling functions
may also diﬀer between DCs located in the alveolar wall and
mucosal DCs that line the conducting airways [47, 50–52].
Although the sampling function of airway DCs ensures
that any inhaled protein will be recognized and presented
to T cells, allergen source-derived proteases compromise
epithelial barrier function by degrading TJ proteins, thus
facilitating allergen delivery across epithelial layers.
Proteases released by major allergenic pollens have
been shown to injure airway epithelial cells in vitro [53].
Proteolytic enzymes contained in pollens of giant ragweed
(Ambrosia triﬁda), white birch, Kentucky blue grass, and
Easter lily (Lilium longiﬂorum) facilitate allergen delivery
across epithelia by degrading occludin, resulting in disrup-
tion of epithelial TJs. This eﬀect was blocked by inhibitors of
serine and cysteine proteases in Madin-Darby canine kidney
(MDCK) and Calu-3 cells [54].
Der p 1 increased epithelial permeability by disrupting
TJs [55]. Immunoblotting demonstrated that the disruption
of TJ morphology by Der p 1 was associated with cleavage
of ZO-1 and occludin in MDCK and 16HBE14o-human
bronchial epithelial cell lines [56]. Putative Der p 1 cleavage
sites were found in peptides from an extracellular domain
of occludin and in the TJ adhesion protein claudin-1.
Extracellular cleavage of TJs initiates intracellular processing
of junctional constituents. Der p 1 is also envisaged toJournal of Allergy 3
operateindirectlyonTJsbyactivatingacellsurfacezymogen,
which then proceeds to cleave TJs [57]. ZO-1 is intracellular
and is therefore unlikely to be directly degraded by Der p 1,
and its breakdown is presumed to be a consequence of TJ
disassembly [57].
Der p 1 and Dermatophagoides farinae 1( D e rf1 )c a ni n -
activate lung surfactant proteins (SP)-A and -D [58], which
are predominantly synthesized and secreted in the lung by
alveolar type II cells and Clara cells. SP-A and-D are known
to play not only signiﬁcant roles in innate immune defense
such as bacterial aggregation and modulation of leukocyte
function, but also are implicated in the allergic response [59,
60].
Allergens, derived from cockroach extracts, are reported
to increase the permeability of bronchial airway epithelial
cells indirectly through the induction of vascular endothelial
growth factor [61] and thereby gain access to intraepithelial
DCs.
Aspergillus fumigatus proteinase directly induces human
epithelial celldetachment [62]. Pen ch 13, a major allergen of
Penicillium chrysogenum, is a serine protease. Its enzymatic
activity damages the epithelial barrier by cleaving the TJ pro-
tein occludin at Gln202 and Gln211, amino acids within the
second extracellular domain of the protein on 16HBE14o-
cells [63], followed by the induction of proinﬂammatory
responses in epithelial cells.
Epithelial injury and aberrant repair are involved in
triggering asthma. Interestingly, Pen ch 13 decreases cell
surface expression of CD44 in 16HBE14o-cells and primary
bronchial epithelial cells [64], which has been suggested to
contribute to repair of epithelial damage [65]. CD44 is a
transmembrane adhesion molecule and the major receptor
for hyaluronan, a major extracellular matrix component.
CD44 is important for the removal of extracellular matrix
from sites of tissue injury, and impaired clearance of
hyaluronan results in persistent inﬂammation [66, 67].
Thus, loss of epithelial barrier function, as a consequence
of proteases associated with allergens, facilitates antigen
access to DCs. The result is that the adaptive immune
response is skewed towards Th2 cells, and the IgE immune
response is ampliﬁed.
Most results are based on in vitro study. Since the diges-
tion process of proteases needs a suﬃentcient local concen-
tration and time, dilution in mucus, as well mucociliary
clearance of the respiratory tract, may complicate the diges-
tion process of TJs in vivo.
4.Allergen Source-DerivedProteasesActivate
PatternRecognition Receptors (PRRs)
Pulmonary epithelial cells are now thought to play vital roles
in both innate and adaptive immune responses. Epithelial
cells can sense and respond to inhaled allergens or proteases
via activation of a variety of pattern recognition receptors
(PRRs) such as TLR and PAR. These activated receptor
signals trigger nuclear factor κB( N F - κB) activation, leading
to transcriptional activation of several proinﬂammatory
genes including those encoding cytokines and chemokines.
Epithelial production of thymic stromal lymphopoietin
(TSLP), granulocyte-macrophage colony stimulating factor
(GM-CSF), and IL-33 and IL-25, as well as the production
of chemokines, both attract and activate DCs, skewing T-cell
production toward to the Th2 subset.
5. PAR-2
Protease allergens are reported to elicit non-IgE-mediated
airway reactions by triggering innate immunity receptors,
such as PARs, to activate epithelial cells, mast cells, and DCs,
which in turn leads to further release of mediators [68].
PARs constitute a novel family of seven-transmembrane G-
protein-coupled receptors. To date, four PARs have been
identiﬁed and cloned. They are widely expressed on cells
comprising blood vessels, connective tissue, epithelium, and
airways, as well as on leukocytes [69]. PARs are activated
by proteolytic cleavage at the amino terminus, allowing
interaction between the newly formed “tethered ligand” and
thesecondextracellularloop of thereceptor.This interaction
confers a cellular signaling property. PARs can also be
activated by small peptides that mimic the tethered ligand.
Activated PARs coupled to G-signaling cascades increase
phospholipase C level, which in turn raises intracellular
calcium (Ca2+)l e v e l[ 70–72]. G protein activation also
generates a transcriptional response through extracellular
signal-regulated and mitogen-activated protein kinases, as
well as NF-κB[ 73–75].
In patients with bronchial asthma, PAR-2 expression is
increased on the surface of respiratory epithelial cells [76,
77]. PAR2 agonists induce constriction of human bronchi
[78]. Lack of PAR-2 expression is reported to lower inﬂam-
matory cell inﬁltration and reduce airway hyperreactivity in
response to allergen challenge in mice [79].
Asthma is associated with increased water and chloride
(Cl−) secretion into the airway lumen due to elevated
expression of Ca2+-activated Cl− channels [80–82]. Stim-
ulation of PAR-2 receptors in mouse and human airways
inhibitedamiloride-sensitivesodium(Na+)conductanceand
stimulated luminal Cl− channels and basolateral potassium
(K+) channels, which together may cause accumulation of
airway surface ﬂuid [83].
Activation of PAR-2 was, however, shown to reduce
airway inﬂammation in a rabbit model of experimental
asthma [84], which supports the concept of PAR-2 being
a cytoprotective receptor involved in prostanoid-dependent
cytoprotection in the airways. Prostaglandin E (PGE),
which inhibits pulmonary inﬁltration by immune cells
and bronchial constriction in allergen-induced asthma, is
produced by cultured airway smooth muscle cells [85, 86],
as well as airway epithelial cells, follicular DCs, ﬁbrob-
lasts, monocytes, and alveolar macrophages [87]. Intranasal
administration of PAR-2-AP was shown to inhibit airway
eosinophilia and hyperresponsiveness in allergic mice via
cyclooxygenase- (COX-) 2-dependent generation of PGE2
[88].
Thus, whether the activation of PAR-2 promotes or
opposes the progression of airway inﬂammatory responses
depends on the experimental model and species and is
not yet fully understood. This is an area requiring further
research.4 Journal of Allergy
PAR-2 is a major candidate for sensing environmental
exposure to serine proteases. PAR-2 is involved in antigen-
induced asthmatic responses, including increase in IgE pro-
duction, a heightened methacholine response, upregulated
production of IL-6, IL-8, GM-CSF, and eotaxin, increased
matrix metalloproteinase-9 (MMP-9) release, and relaxation
of bronchi [89, 90]. Interestingly, MMP-9, which plays an
important role in remodeling of the airways in disease, is
hypothesizedtoexertitseﬀectsontheepitheliumbycleaving
one or more components of cell-cell junctions and triggering
anoikis [91].
Increased release of proinﬂammatory cytokines, such as
IL-6 and IL-8, from airway epithelial cells in response to
proteases contained HDM [92, 93]. Der p 3 and Der p 9 may
induce a non-allergic inﬂammatory response in the airways,
via release of proinﬂammatory cytokines from the bronchial
epithelium, which is at least partially mediated by PAR-2
[94]. Although release of IL-6 and IL-8, due to the protease
activity of Der p 1, can occur via a mechanism independent
of Ca2+ mobilization and PAR activation [95, 96], their
release from an A549 cell line was reported to be associated
with PAR-2 [97].
Fungal proteases, from Aspergillus fumigates, Alternaria
alternate,andCladosporiumherbarum,diﬀerentiallyinduced
morphologic changes, cell desquamation, and the produc-
tion of various cytokines [98, 99] .T h ep r o t e a s ea c t i v i t y
of Pen ch 13, an allergen from Penicillium chrysogenum,
is required for the induction of PGE2, IL-8, transforming-
growth-factor- (TGF-) beta1 and COX-2 expression in A549
cells, 16HBE14o-cells, and primary cultures of HBEpC [63].
Penc13,themainallergenproducedbyPenicilliumcitrinum,
induces the expression of IL-8 in human airway epithelial
cells by activating either PAR-1 or PAR-2 [100].
Fecalremnants[101]andextracts[102]ofGermanc ock-
roach induced mucosal allergic sensitization and inﬂamma-
tion via PAR-2 in mice. Inﬂammatory responses of human
eosinophils to German and Oriental cockroach (Blatta
orientalis) extract antigens are mediated via PAR-2 [27,
103]. Recent data provide evidence implicating the protease
activity of cockroaches in cytokine regulation. Allergens of
German and American cockroaches induce IL-8 expression
in H292 cells [104] and A549 cells [105], respectively, and
both are blocked by serine protease inhibitors, suggesting
PAR-2 might play a role in cockroach allergen-induced
IL-8 secretion from human airway epithelial cells [105].
Proteases in German cockroach extract regulate PAR-2 and
extracellular signal-regulated kinase (ERK) to increase NF
for IL-6 (NF-IL6) activity (recently known as C/EBP-β),
as well as synergistically regulating TNF-α-induced IL-8
promoter activity in the human airway epithelium [104,
106–108]. German cockroach fecal remnants contain active
serine proteases, which augment TNF-α-induced MMP-9
expression via a mechanism that involves PAR-2, ERK, and
AP-1 [109].
Interestingly, exposure to inhaled antigens with a PAR-
2-activating peptide led to allergic sensitization, whereas
exposure to Ag alone induced tolerance in BALB/c mice
administeredovalbumin(OVA),suggestingPAR-2activation
in the airways at the time of inhaled antigen exposure to be
capable of shifting the resulting immune response toward
allergic sensitization and the development of asthma. Fur-
thermore, PAR-2-mediated allergic sensitization is reported
to be TNF dependent [110].
6.ThymicStromalLymphopoietin
In addition to serving as a physical barrier, airway epithelial
cells are now thought to play essential roles in allergic
responses. TSLP [111] is expressed mainly by epithelial cells
comprising the barriersurfacesofthelungs. Genetic analyses
of atopic populations have demonstrated polymorphisms in
TSLP to be associated with asthma and airway hyperrespon-
siveness, IgE concentration, and eosinophilia [112–116].
Overexpression of TSLP in the lungs can trigger Th2 cell
immunity. Mice expressing TSLP in the lungs spontaneously
developanairwayinﬂammatorydisorderwithcharacteristics
similar to those of human asthma [117].
Studies of endobronchial biopsy specimens and BAL
ﬂuid of subjects with severe asthma have shown that asthma
is associated with elevated bronchial mucosal expression
of TSLP and Th1-attracting (IP-10/CXCL10) and Th2-
attracting (TARC/CCL17, MDC/CCL22) chemokines [118,
119].
IL-25 and TSLP perform important functions in the
initiation of allergic responses [120–122]. TSLP expression
is induced in airway epithelial cells by exposure to allergen-
derived proteases, and PAR-2 is involved in this process. A
recent study demonstrated upregulation of IL-25 and TSLP
mRNA in pulmonary epithelial cells after protease allergen
treatment in vivo and in vitro, and that the induction of IL-
25 and TSLP occurs via the intracellular ERK and p38 MAP
kinase pathways [123]. TSLP induces the innate immune
functions of DCs, leading to chemokine-driven recruitment
of Th2 cells to the airway, and these cells then produce Th2
typecytokines.TSLPalsotriggersthematurationofDCsand
their migration to mediastinal lymph nodes, again skewing
the T-cell distribution in favor of inﬂammatory Th2 cells
producing IL-4, IL-5, IL-13, and TNF-α. These processes
involve interactions between costimulatory molecules, such
as OX40 (CD134) in the membranes of na¨ ıve T cells and
OX40L (CD134L) in the membranes of DCs [124, 125].
TSLP was reported to be induced in the airway epithelial cell
line BEAS-2B by exposure to Alternaria proteases [126] (see
Figure 1).
Basophils are directly activated by protease allergens
and produce TSLP. Cysteine protease activity of papain, an
occupational allergen homologous to Der f 1 and Der p 1,
was reported to initiate Th2 sensitization in vivo in mice via
activation of basophils [122].
7.Allergen Source-DerivedProteases
EnhanceSensitizationtoOtherAllergens
andAllergen Components
The tertiary structure of an allergen is involved in IgE-
binding activity. The tertiary architecture of the Der p 1
molecule itself is not suﬃcient to induce major productionJournal of Allergy 5
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Figure 1: Allergen source-derived proteases compromise epithelial barrier function by degrading TJ proteins, facilitating allergen
accessibility to DCs. Enzymatically active allergens can activate PAR to induce TSLP. TSLP induces immediate innate immune functions
in DCs, leading to recruitment of inﬂammatory cells. TSLP triggers the maturation of DCs, so they migrate to mediastinal lymph nodes.
Induction of DCs to upregulate OX40L by TSLP promotes Th2 responses. PAR also upregulates production of MMP-9, which degrades tight
junction proteins. Thus, impairment of airway epithelial barrier function and activation of epithelial cells are involved in the pathogenesis
of inﬂammation mediated by allergen source-derived proteases.
of both IgE and IgG, but its proteolytic activity is crucial for
eliciting positive immune responses in na¨ ıve mice [127].
Immunization of mice with proteolytically active Der p
1 results in signiﬁcant increases in total IgE and Der p 1-
speciﬁc IgE synthesis, as compared with animals immunized
with Der p 1 irreversibly blocked with E-64, a cysteine
protease inhibitor [128]. The proteolytic activity of Der p 1
heightens inﬂammatory cell inﬁltration into the lungs and
systemic IgE production when administered directly into the
respiratory tract [129].
Allergens with protease activity are also able to mediate
sensitization to nonprotease proteins. Exposure to HDM
extract establishes a mucosal environment fostering the
development of allergic sensitization to otherwise weak or
innocuous antigens, such as OVA, suggesting that whether
an airborne allergen will generate allergic airway disease may
depend, at least in part, not simply on being exposed to
it but rather the setting in which that exposure takes place
[130, 131].
Active protease contents of fungal extracts can inﬂuence
the induction and severity of allergic airway disease in
mice. Proteolytically active molecules can facilitate the
presentation of nonproteolytic allergens to the immune
system, thereby augmenting sensitization to allergens. These
proteolytic allergens thereby promote Th2 cell sensitization.
For a mature response, the participation of components
such as enzymes may have a major role, as is suggested by
the response reported with crude antigen and recombinant
allergens. Alkaline serine proteases are major allergens of
Aspergillus species. The alkaline serine protease allergen of A.
fumigatus (Asp f 13) induces IgE as well as an inﬂammatory
response and has synergistic eﬀects on the Asp f 2-induced
immune response in mice [31, 132].
8.Allergen Source-DerivedProteases
Cleave CellSurfaceMolecules:Roles
beyondthe Airways
Allergen source-derived proteases have been recognized as
having the ability to cleave key regulatory molecules in
allergic reactions involving cell surfaces, and to amplify IgE
responses.
Previously suggested pathogenic roles of exogenous
proteases, especially Der p 1, involve cleavage of various
endogenous proteins, including removal of low-aﬃnity IgER
(CD23) from the surface of human B lymphocytes. This
loss of cell surface CD23 from IgE-secreting B cells may
promote and amplify IgE immune responses by eliminating
an important inhibitory feedback mechanism that would
normally limit IgE synthesis. Furthermore, fragments of
CD23 released by Der p 1 may directly promote IgE synthesis
[133].
Der p 1 cleaves the α subunit of the IL-2 receptor (IL-
2R or CD25), which is pivotal for Th1 cell propagation,
removing it from the surface of human peripheral blood
T cells. As a result, these cells show markedly diminished
proliferation and interferon γ s e c r e t i o ni nr e s p o n s et oa
potent stimulus such as anti-CD3 antibody. IL-2R cleavage
by Der p 1 is likely to cause impaired growth of cells of
the Th1 subset and may, as a consequence, bias the immune
response toward Th2 cells [134, 135].
Der p 1 also cleaves cell surface DC-SIGN and DC-
SIGNR, which are closely related C-type lectin transmem-
brane receptors expressed within compartments of the
immune system. These molecules then bind to intracellular
adhesion molecule-2 (ICAM-2), expressed on endothelial
and T cells, and ICAM-3, expressed on T cells. Both are6 Journal of Allergy
involved in DC traﬃcking, DC-T-cell interactions, and
skewing of the immune response in favor of Th 1 [136].
P r o t e o l y t i ca c t i v i t yo fD e rp1r e s u l t si nc l e a v a g eo f
CD40 from the DC surface. This deprives DCs of the ability
to receive CD40L-mediated signals from T cells, which is
an important pathway stimulating IL-12 production. This
downregulationofIL-12mayenableDCstodirectlypromote
the diﬀerentiation of na¨ ıve T cells toward the Th2 cytokine
proﬁle [137].
9. Conclusion
Although genetic aspects of airway epithelium barrier deﬁ-
ciency have yet to be determined, both structural and
functional abnormalities of the epithelium underlie the
pathogenesis of bronchial asthma. Protease activity in aller-
gens conﬁrms that allergenicity not only results from the
reaction to an epitope, which is involved in adaptive immune
responses by T and B cells, but also from disruption of
airway barrier function and activation of innate immune
responses through epithelial cells [138–140]. Stimulation of
PAR-2 signaling by protease allergens participates in the
inﬂammatoryprocess,andmayserveasalinkbetweeninnate
a n da d a p t i v ei m m u n er e s p o n s e s .
Analysis of these allergen proteases, which constitute
protease-sensing pathways in airway epithelial cells, is essen-
tial for elucidating the pathogenesis of allergic asthma. A
full understanding of these processes is anticipated to lead
to both treatment and preventive measures against asthma
development.
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